deferoxamine has been researched along with hydralazine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Anderson, KE | 1 |
| Hill, NS; Preston, IR; Suzuki, YJ; Wong, CM | 1 |
| Huang, Y; Wong, CM; Zhang, Y | 1 |
1 review(s) available for deferoxamine and hydralazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for deferoxamine and hydralazine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Effects of antihypertensive drugs on hepatic heme biosynthesis, and evaluation of ferrochelatase inhibitors to simplify testing of drugs for heme pathway induction.
Topics: 5-Aminolevulinate Synthetase; Animals; Antihypertensive Agents; Chick Embryo; Cytochrome P-450 Enzyme System; Deferoxamine; Dose-Response Relationship, Drug; Enzyme Induction; Ferrochelatase; Heme; Hydralazine; Liver; Porphyrins | 1978 |
Iron chelation inhibits the development of pulmonary vascular remodeling.
Topics: Animals; Blood Proteins; Case-Control Studies; Cell Proliferation; Cells, Cultured; Deferoxamine; Female; Humans; Hydralazine; Hypertension, Pulmonary; Iron Chelating Agents; Male; Middle Aged; Myocardial Contraction; Myocytes, Smooth Muscle; Oxidation-Reduction; Protein Carbonylation; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; rho Guanine Nucleotide Dissociation Inhibitor alpha; Vasodilator Agents | 2012 |
Bone morphogenic protein-4-induced oxidant signaling via protein carbonylation for endothelial dysfunction.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Aorta; Apoptosis; Bone Morphogenetic Protein 4; Cells, Cultured; Deferoxamine; Diabetes Mellitus; Diabetic Angiopathies; Endothelial Cells; Endothelium, Vascular; Hydralazine; Hyperglycemia; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Oxidation-Reduction; Oxidative Stress; Protein Carbonylation; Rats; Reactive Oxygen Species; Vasodilation; Vasodilator Agents | 2014 |